Global Biological and Chemical Indicators Market Poised for Remarkable Growth: Expected to Reach USD 866.9 Million by 2033

The global biological and chemical indicators market is on the brink of unprecedented growth, with market research forecasting a significant increase in market value from USD 490.3 million in 2023 to an impressive USD 866.9 million by 2033. This expansion represents a robust Compound Annual Growth Rate (CAGR) of 5.9% throughout the forecast period.

The primary driver behind this growth is the growing emphasis on patient safety and infection control across the global healthcare sector. As healthcare institutions prioritize these critical areas, the demand for reliable and efficient biological and chemical indicators has surged. These indicators play an essential role in ensuring the sterility of medical devices and environments, thereby safeguarding patient health.

Moreover, the market’s expansion is fueled by the increasing awareness and stringent regulations surrounding infection control practices. As healthcare standards evolve, the need for accurate and reliable indicators has never been more critical.

Technological Advancements and Industry Dynamics:

Advancements in technology and the development of innovative products are pivotal to the market’s growth. These technological strides have enhanced the accuracy and reliability of biological and chemical indicators, making them indispensable tools in the healthcare industry. Continuous innovation has led to the proliferation of new products and services, contributing to the heightened competition within the market.

Key industry players, including 3M Company, Mesa Laboratories Inc., Steris plc, Getinge AB, and TSO3 Inc., have established themselves as leaders by offering cutting-edge products, investing heavily in research and development, and fostering strong customer relationships.

Strategic Collaborations and Market Consolidation:

In the race for market dominance, companies are increasingly leveraging strategic collaborations and mergers and acquisitions. For instance, Mesa Laboratories Inc. has partnered with the University of Colorado to develop advanced sterilization products, while 3M Company acquired Acelity Inc. in 2020 to expand its product offerings in advanced wound care.

Global Market Highlights:

  • The United States is expected to lead the market, with an estimated value of USD 169.4 million by 2033, growing at a CAGR of 4.9%.
  • Germany’s market is projected to reach USD 20.7 million by 2033, with a CAGR of 3.7%.
  • The United Kingdom is expected to witness a CAGR of 6.0%, reaching USD 19.5 million by 2033.
  • China’s market is anticipated to grow to USD 32.7 million by 2033, with a CAGR of 5.3%.

Get Old Source Has Released the Latest Reports

Key Companies Profiled:

  • The 3M Company
  • Steris Plc.
  • Thermo Fisher Scientific, Inc.
  • Mesa Labs, Inc.
  • McKesson Medical-Surgical Inc.
  • Crosstex International, Inc.
  • Propper Manufacturing Co., Inc.
  • Terragene S.A.
  • Andersen Products, Inc.
  • Getinge AB
  • GKE-GmbH
  • Liofilchem S.r.l.
  • Protak Scientific Ltd.
  • ParaSure Limited
  • Excelsior Scientific
  • Siltex Australia Pvt. Ltd.

Biological and Chemical Indicators Industry by Category:

By Sterilization Type:

  • Thermal Sterilization
    • Steam Heat
    • Dry Heat
  • Chemical Sterilization
    • Ethylene Oxide
    • Hydrogen Peroxide
    • Formaldehyde
  • Radiation Sterilization

By Indicator Class:

  • Biological Indicators
    • Geobacillus stearothermophilus (GS) Spores
    • Bacillus atrophaeus (BA) Spores
    • Others
  • Chemical Indicators
    • Class 1 (Process)
    • Class 4 (Multi-Variable)
    • Class 2 (Specific-Use)
    • Class 3 (Single-Variable)
    • Class 5 (Integrating)
    • Class 6 (Cycle Verification)
  • Enzyme Indicators

By Packaging Form:

  • Self-Contained BI
  • Spore Suspension BI
  • Strip and Disc BI
  • Strip and Disc CI
  • Others

By End User:

  • Biopharma Industry
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Labs
  • Research Lab

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle-East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *